Monitoring the Quality of Life of Patients With End-stage Renal Disease (QV-REIN)
NCT ID: NCT02890264
Last Updated: 2016-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2005-01-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective is : To describe the quality of life of patients with major end-stage renal disease treated with dialysis method for at least one year.
The seconds objectives are :
* To contribute to the knowledge of the key determinants of the quality of life among chronic renal failure patients.
* To study the influence on way of giving a questionnaire about assessment of level of quality of life
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
French Renal Epidemiology and Information Network (REIN) Registry
NCT03967808
Exploring Predictors of Quality of Life in Older Adults With End-Stage Kidney Disease Receiving In-Center Hemodialysis
NCT07129083
Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease
NCT06495385
Registry for End Stage Renal Failure
NCT02895425
Follow-up of Long-term Renal Function After Acute Kidney Injury in ICU
NCT03302624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Three studies will be carried out between 2005 and 2010. The progress of each study is the same.
The random draw of eligible patients, according to a stratification by region and age group is carried out by the Biostatistics and Medical Informatics Service of the Necker Hospital in Paris, responsible for basic SIMS-REIN, for data center in the regions Champagne-Ardenne, Languedoc-Roussillon, Limousin and Provence-Alpes-Côte d'Azur. For Auvergne, Bretagne, Lorraine and Rhône-Alpes, which operate independently for the collection of data REIN, the random draw of patients is done by each epidemiological center responsible for this collection.
The Biostatistics and Medical Informatics Service of the Necker Hospital, and epidemiological centers of Auvergne, Bretagne, Lorraine and Rhône Alpes must submit the list of selected patients Clinical Research Associate (CRA) national.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age at least 18 years old at the time of dialysis at
* Treaty within one of the nine aforementioned regions
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GUILLEMIN Francis, MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Serge BRIANCON
Role: PRINCIPAL_INVESTIGATOR
Central Hospital Nancy
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.